Sionna Therapeutics Inc

TPG GP A, LLC sells 250,000 Sionna shares at $40 each – a subtle liquidity move that signals caution for investors watching Phase‑2 trials and future capital raises.

TPG GP A, LLC sells 250k Sionna shares at $40—an ordinary portfolio shuffle that leaves the biotech’s long‑term outlook unchanged and its stock steady near a 52‑week high.